Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma
Status unconfirmed
Conditions studied: Squamous Cell Carcinoma
In brief
The goal of this study is to determine the optical spectroscopy characteristics of tumor in patients with head and neck squamous cell carcinoma (HNSCC). HNSCC constitutes over 90% of all head and neck cancers. These spectroscopy measurements will be compared with pathological diagnosis of tissue biopsies from the same site. These readings will be performed in the operating room during routine endoscopy with biopsy and tumor mapping of patients who have a suspected squamous cell carcinoma of the head and/or neck. Furthermore, a built in pressure sensor will be used to compare biopsy sites with their benign counterparts. If successful, the optical measurements could be used to survey for and delineate the extent of malignancies in a noninvasive manner. This would be especially helpful for clinic visits where suspicious lesions are seen and would otherwise require biopsy for diagnosis. Immediate benefits would include patients with unknown primaries in which numerous directed biopsies are obtained from multiple head and neck sites.
Key facts
- Study ID
- NCT02943044
- Run by
- Zenalux Biomedical, Inc.
- People needed
- 50
- Starts
- 2016-12-01
- Expected to finish
- 2017-12-01
- Last updated by the study team
- 2017-03-03
Who can join
Age: 24 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing panendoscopy and biopsy for suspected squamous cell carcinoma of the head and neck.
- patient is > 24 to <89 years of age
- Ability to understand and the willingness to sign a written informed consent document.
You may not qualify if…
- < 24 years of age, >89 years of age
- Unable to provide written informed consent.
Where it is running
- Duke University Medical Center — Durham, North Carolina, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.